PL373802A1 - Polimorficzne formy pochodnych fenylooksazolidynonu - Google Patents

Polimorficzne formy pochodnych fenylooksazolidynonu

Info

Publication number
PL373802A1
PL373802A1 PL03373802A PL37380203A PL373802A1 PL 373802 A1 PL373802 A1 PL 373802A1 PL 03373802 A PL03373802 A PL 03373802A PL 37380203 A PL37380203 A PL 37380203A PL 373802 A1 PL373802 A1 PL 373802A1
Authority
PL
Poland
Prior art keywords
polymorphic forms
oxazolidinone derivatives
phenyl oxazolidinone
phenyl
derivatives
Prior art date
Application number
PL03373802A
Other languages
English (en)
Inventor
Biswajit Das
Anita Mehta
Ashok Rattan
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of PL373802A1 publication Critical patent/PL373802A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL03373802A 2002-05-15 2003-05-15 Polimorficzne formy pochodnych fenylooksazolidynonu PL373802A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38060602P 2002-05-15 2002-05-15

Publications (1)

Publication Number Publication Date
PL373802A1 true PL373802A1 (pl) 2005-09-19

Family

ID=29549983

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03373802A PL373802A1 (pl) 2002-05-15 2003-05-15 Polimorficzne formy pochodnych fenylooksazolidynonu

Country Status (13)

Country Link
US (1) US20050209248A1 (pl)
EP (1) EP1505978A1 (pl)
JP (1) JP2005529924A (pl)
KR (1) KR20040106551A (pl)
CN (1) CN1662240A (pl)
AU (1) AU2003230076A1 (pl)
BR (1) BR0310074A (pl)
CA (1) CA2483600A1 (pl)
NZ (1) NZ536488A (pl)
PL (1) PL373802A1 (pl)
RU (1) RU2004136573A (pl)
WO (1) WO2003097059A1 (pl)
ZA (1) ZA200409944B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE471937T1 (de) 2003-07-02 2010-07-15 Merck Sharp & Dohme Cyclopropylgruppensubstituierte oxazolidinonantibiotika und derivate davon
EP1874782A1 (en) 2005-04-15 2008-01-09 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
KR20110092309A (ko) 2008-11-20 2011-08-17 파나세아 바이오테크 리미티드 신규 항균제
CA2765692A1 (en) 2009-06-26 2010-12-29 Panacea Biotec Ltd. Novel azabicyclohexanes
WO2021258013A1 (en) 2020-06-18 2021-12-23 Akagera Medicines, Inc. Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4921869A (en) * 1987-10-09 1990-05-01 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
EP1019385B1 (en) * 1995-09-15 2004-01-14 PHARMACIA & UPJOHN COMPANY Aminoaryl oxazolidinone n-oxides
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
MY116093A (en) * 1996-02-26 2003-11-28 Upjohn Co Azolyl piperazinyl phenyl oxazolidinone antimicrobials
AU6937001A (en) * 2000-07-17 2002-01-30 Ranbaxy Lab Ltd Oxazolidinone derivatives as antimicrobials

Also Published As

Publication number Publication date
CN1662240A (zh) 2005-08-31
NZ536488A (en) 2005-09-30
EP1505978A1 (en) 2005-02-16
WO2003097059A1 (en) 2003-11-27
US20050209248A1 (en) 2005-09-22
WO2003097059A8 (en) 2005-02-17
KR20040106551A (ko) 2004-12-17
ZA200409944B (en) 2005-06-08
CA2483600A1 (en) 2003-11-27
BR0310074A (pt) 2005-03-08
RU2004136573A (ru) 2005-08-10
AU2003230076A1 (en) 2003-12-02
JP2005529924A (ja) 2005-10-06

Similar Documents

Publication Publication Date Title
AP1967A (en) Thiazolidinone compounds as inhibitors of Hyak3
CY2015036I2 (el) Νεα παραγωγα οξαζολιδινονης
PL377087A1 (pl) Związki heterocykliczne
ZA200605348B (en) Solid forms of anti-EGFR-antibodies
IL209082A0 (en) Fushed heterocyclic compounds
IL175065A0 (en) Amide derivatives
AU2003287979A8 (en) Phenyl compounds
LT3002283T (lt) Tiazolo dariniai
IL206050A0 (en) Oxazole derivatives of tetracyclines
EP1652843A4 (en) AMIDE DERIVATIVES
IL163820A0 (en) Crystalline polymorphic form of irinotecan hydrochloride
PL376604A1 (pl) Polimorfy chlorowodorku bicifadyny
EP1476425A4 (en) Heterocyclic Aryl Sulphonamidocyclic Compounds
GB0329572D0 (en) Amide derivatives
PL378760A1 (pl) Pochodne oksazoli jako inhibitory cyklooksygenazy
AU2003245027A1 (en) Novel crystalline forms of ziprasidone hydrochloride
IL175514A0 (en) Polymorphic form b2 of ziprasidone base
IL174213A0 (en) A polymorphic form of 3-phenylsulfonyl-8-piperazin-1-yl-quinoline
IL165115A0 (en) Novel crystalline forms of gatifloxacin
PL373802A1 (pl) Polimorficzne formy pochodnych fenylooksazolidynonu
EP1620101A4 (en) POLYMORPHS OF CABERGOLIN
IL156669A0 (en) 2-aminobenzoyl derivatives
IL166308A0 (en) Polymorphic forms of nateglinide
IL166592A0 (en) Novel crystalline forms of gatifloxacin
IL165690A0 (en) Novel crystalline forms of gatifloxacin

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)